EYE(EYE)
EYE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $2.06B | $2.18B | $2.36B | $2.48B |
| Low | $2.03B | $2.15B | $2.34B | $2.45B |
| High | $2.07B | $2.22B | $2.42B | $2.52B |
| EBITDA Avg | $156M | $165M | $179M | $188M |
| Low | $154M | $163M | $177M | $186M |
| High | $157M | $169M | $183M | $191M |
| EBIT Avg | $49M | $52M | $56M | $59M |
| Low | $49M | $51M | $56M | $58M |
| High | $49M | $53M | $58M | $60M |
| Net Income Avg | $78M | $96M | $122M | $131M |
| Low | $72M | $81M | $120M | $129M |
| High | $82M | $104M | $124M | $134M |
| EPS Avg | $0.96 | $1.18 | $1.51 | $1.63 |
| Low | $0.89 | $1.01 | $1.49 | $1.60 |
| High | $1.02 | $1.29 | $1.54 | $1.66 |
| Analysts (Rev / EPS) | 8 / 7 | 8 / 7 | 4 / 1 | 2 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $516M | $504M | $574M | $524M | $544M | $521M |
| Low | $511M | $500M | $568M | $519M | $539M | $516M |
| High | $521M | $511M | $582M | $532M | $552M | $529M |
| EBITDA Avg | $39M | $38M | $44M | $40M | $41M | $39M |
| Low | $39M | $38M | $43M | $39M | $41M | $39M |
| High | $40M | $39M | $44M | $40M | $42M | $40M |
| EBIT Avg | $12M | $12M | $14M | $13M | $13M | $12M |
| Low | $12M | $12M | $14M | $12M | $13M | $12M |
| High | $12M | $12M | $14M | $13M | $13M | $13M |
| Net Income Avg | $16M | $10M | $41M | $19M | $20M | $14M |
| Low | $15M | $10M | $40M | $18M | $20M | $14M |
| High | $17M | $13M | $42M | $19M | $21M | $14M |
| EPS Avg | $0.20 | $0.13 | $0.51 | $0.23 | $0.25 | $0.17 |
| Low | $0.18 | $0.13 | $0.50 | $0.23 | $0.25 | $0.17 |
| High | $0.21 | $0.16 | $0.52 | $0.24 | $0.26 | $0.18 |
| Analysts (Rev / EPS) | 6 / 7 | 10 / 12 | 5 / 5 | 5 / 5 | 5 / 5 | 4 / 7 |